{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,11,11]],"date-time":"2026-11-11T03:06:59Z","timestamp":1794366419180,"version":"4.9.0"},"reference-count":47,"publisher":"Springer Science and Business Media LLC","issue":"1","license":[{"start":{"date-parts":[[2026,5,23]],"date-time":"2026-05-23T00:00:00Z","timestamp":1779494400000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by-nc-nd\/4.0"},{"start":{"date-parts":[[2026,7,20]],"date-time":"2026-07-20T00:00:00Z","timestamp":1784505600000},"content-version":"vor","delay-in-days":58,"URL":"https:\/\/creativecommons.org\/licenses\/by-nc-nd\/4.0"}],"funder":[{"DOI":"10.13039\/501100004735","name":"Hunan Provincial Natural Science Foundation of China","doi-asserted-by":"crossref","award":["2023JJ30804"],"award-info":[{"award-number":["2023JJ30804"]}],"id":[{"id":"10.13039\/501100004735","id-type":"DOI","asserted-by":"crossref"}]},{"DOI":"10.13039\/501100001809","name":"National Natural Science Foundation of China","doi-asserted-by":"crossref","award":["82572252"],"award-info":[{"award-number":["82572252"]}],"id":[{"id":"10.13039\/501100001809","id-type":"DOI","asserted-by":"crossref"}]}],"content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":["J Nanobiotechnol"],"DOI":"10.1186\/s12951-026-04578-w","type":"journal-article","created":{"date-parts":[[2026,5,23]],"date-time":"2026-05-23T02:25:51Z","timestamp":1779503151000},"update-policy":"https:\/\/doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":3,"title":["Ultrasound-responsive biomimetic nanocarrier triggers spatiotemporal PROTAC release and ROS storm to disrupt TNBC immunosuppression via coordinated apoptosis\/ferroptosis\/senescence activation"],"prefix":"10.1186","volume":"24","author":[{"given":"Zhipeng","family":"Liao","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Haiqin","family":"Liao","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Yi","family":"Luo","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Sihan","family":"Chen","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Yuanyuan","family":"Shen","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Ming","family":"Zhang","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Yan","family":"Xu","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Long","family":"Wang","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Chengcheng","family":"Niu","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"297","published-online":{"date-parts":[[2026,5,23]]},"reference":[{"issue":"3","key":"4578_CR1","first-page":"229","volume":"74","author":"F Bray","year":"2024","unstructured":"Bray F, Laversanne M, Sung H, Ferlay J, Siegel RL, Soerjomataram I, et al. Global cancer statistics 2022: GLOBOCAN estimates of incidence and mortality worldwide for 36 cancers in 185 countries. CA Cancer J Clin. 2024;74(3):229\u201363.","journal-title":"CA Cancer J Clin"},{"issue":"4","key":"4578_CR2","doi-asserted-by":"publisher","first-page":"1154","DOI":"10.1038\/s41591-025-03502-3","volume":"31","author":"J Kim","year":"2025","unstructured":"Kim J, Harper A, McCormack V, Sung H, Houssami N, Morgan E, et al. Global patterns and trends in breast cancer incidence and mortality across 185 countries. Nat Med. 2025;31(4):1154\u201362.","journal-title":"Nat Med"},{"issue":"8","key":"4578_CR3","doi-asserted-by":"publisher","first-page":"554","DOI":"10.1038\/s41568-024-00714-6","volume":"24","author":"MA Harris","year":"2024","unstructured":"Harris MA, Savas P, Virassamy B, O\u2019Malley MMR, Kay J, Mueller SN, et al. Towards targeting the breast cancer immune microenvironment. Nat Rev Cancer. 2024;24(8):554\u201377.","journal-title":"Nat Rev Cancer"},{"issue":"2","key":"4578_CR4","doi-asserted-by":"publisher","first-page":"91","DOI":"10.1038\/s41571-021-00565-2","volume":"19","author":"G Bianchini","year":"2021","unstructured":"Bianchini G, De Angelis C, Licata L, Gianni L. Treatment landscape of Triple-Negative Breast Cancer \u2014 expanded options, evolving needs. Nat Rev Clin Oncol. 2021;19(2):91\u2013113.","journal-title":"Nat Rev Clin Oncol"},{"issue":"1","key":"4578_CR5","doi-asserted-by":"publisher","first-page":"181","DOI":"10.1146\/annurev-pathol-042420-093238","volume":"17","author":"F Derakhshan","year":"2022","unstructured":"Derakhshan F, Reis-Filho JS. Pathogenesis of Triple-Negative Breast Cancer. Annu Rev Pathol. 2022;17(1):181\u2013204.","journal-title":"Annu Rev Pathol"},{"issue":"1","key":"4578_CR6","doi-asserted-by":"publisher","DOI":"10.1186\/s12943-023-01850-7","volume":"22","author":"Y Liu","year":"2023","unstructured":"Liu Y, Hu Y, Xue J, Li J, Yi J, Bu J, et al. Advances in immunotherapy for Triple-Negative Breast Cancer. Mol Cancer. 2023;22(1):145.","journal-title":"Mol Cancer"},{"issue":"1","key":"4578_CR7","doi-asserted-by":"publisher","first-page":"121","DOI":"10.1186\/s13045-022-01341-0","volume":"15","author":"Y Li","year":"2022","unstructured":"Li Y, Zhang H, Merkher Y, Chen L, Liu N, Leonov S, et al. Recent advances in therapeutic strategies for triple-negative breast cancer. J Hematol Oncol. 2022;15(1):121.","journal-title":"J Hematol Oncol"},{"issue":"2","key":"4578_CR8","doi-asserted-by":"publisher","first-page":"537","DOI":"10.1007\/s10555-021-09972-4","volume":"40","author":"AL Heeke","year":"2021","unstructured":"Heeke AL, Tan AR. Checkpoint inhibitor therapy for metastatic Triple-Negative Breast Cancer. Cancer Metastasis Rev. 2021;40(2):537\u201347.","journal-title":"Cancer Metastasis Rev"},{"issue":"12","key":"4578_CR9","doi-asserted-by":"publisher","first-page":"912","DOI":"10.1038\/s41577-024-01102-9","volume":"24","author":"G Kroemer","year":"2024","unstructured":"Kroemer G, Mont\u00e9gut L, Kepp O, Zitvogel L. The danger theory of immunity revisited. Nat Rev Immunol. 2024;24(12):912\u201328.","journal-title":"Nat Rev Immunol"},{"key":"4578_CR10","doi-asserted-by":"crossref","unstructured":"Deng W, Shang H, Tong Y, Liu X, Huang Q, He Y, et al. The application of nanoparticles-based ferroptosis, pyroptosis and autophagy in cancer immunotherapy. J Nanobiotechnology. 2024;22(1):97.","DOI":"10.1186\/s12951-024-02297-8"},{"key":"4578_CR11","doi-asserted-by":"publisher","DOI":"10.1016\/j.ccr.2024.216236","volume":"522","author":"N Singh","year":"2025","unstructured":"Singh N, Kim D, Min S, Kim E, Kim S, Zhang YS, et al. Multimodal synergistic ferroptosis cancer therapy. Coord Chem Rev. 2025;522:216236.","journal-title":"Coord Chem Rev"},{"key":"4578_CR12","doi-asserted-by":"publisher","DOI":"10.1016\/j.biopha.2024.117298","volume":"179","author":"X Li","year":"2024","unstructured":"Li X, Li Y, Tuerxun H, Zhao Y, Liu X, Zhao Y. Firing up \u201ccold\u201d tumors: ferroptosis causes immune activation by improving T cell infiltration. Biomed Pharmacother. 2024;179:117298.","journal-title":"Biomed Pharmacother"},{"issue":"4","key":"4578_CR13","doi-asserted-by":"publisher","first-page":"487","DOI":"10.1038\/s41590-022-01132-2","volume":"23","author":"G Kroemer","year":"2022","unstructured":"Kroemer G, Galassi C, Zitvogel L, Galluzzi L. Immunogenic cell stress and death. Nat Immunol. 2022;23(4):487\u2013500.","journal-title":"Nat Immunol"},{"issue":"6","key":"4578_CR14","doi-asserted-by":"publisher","first-page":"445","DOI":"10.1038\/s41573-024-00920-9","volume":"23","author":"L Galluzzi","year":"2024","unstructured":"Galluzzi L, Guilbaud E, Schmidt D, Kroemer G, Marincola FM. Targeting immunogenic cell stress and death for cancer therapy. Nat Rev Drug Discov. 2024;23(6):445\u201360.","journal-title":"Nat Rev Drug Discov"},{"issue":"5","key":"4578_CR15","doi-asserted-by":"publisher","first-page":"407","DOI":"10.1016\/j.trecan.2024.01.013","volume":"10","author":"E Catanzaro","year":"2024","unstructured":"Catanzaro E, Demuynck R, Naessens F, Galluzzi L, Krysko DV. Immunogenicity of ferroptosis in cancer: a matter of context? Trends Cancer. 2024;10(5):407\u201316.","journal-title":"Trends Cancer"},{"issue":"6","key":"4578_CR16","doi-asserted-by":"publisher","first-page":"340","DOI":"10.1038\/s41568-022-00450-9","volume":"22","author":"L Wang","year":"2022","unstructured":"Wang L, Lankhorst L, Bernards R. Exploiting senescence for the treatment of cancer. Nat Rev Cancer. 2022;22(6):340\u201355.","journal-title":"Nat Rev Cancer"},{"issue":"2","key":"4578_CR17","doi-asserted-by":"publisher","first-page":"410","DOI":"10.1158\/2159-8290.CD-22-0523","volume":"13","author":"I Marin","year":"2023","unstructured":"Marin I, Boix O, Garcia-Garijo A, Sirois I, Caballe A, Zarzuela E, et al. Cellular Senescence Is Immunogenic and Promotes Antitumor Immunity. Cancer Discov. 2023;13(2):410\u201331.","journal-title":"Cancer Discov"},{"issue":"1","key":"4578_CR18","doi-asserted-by":"publisher","DOI":"10.1038\/s41467-024-54132-1","volume":"16","author":"HJ Hwang","year":"2025","unstructured":"Hwang HJ, Kang D, Shin J, Jung J, Ko S, Jung KH, et al. Therapy-induced senescent cancer cells contribute to cancer progression by promoting ribophorin 1-dependent PD-L1 upregulation. Nat Commun. 2025;16(1):353.","journal-title":"Nat Commun"},{"issue":"1","key":"4578_CR19","doi-asserted-by":"publisher","first-page":"420","DOI":"10.1038\/s41392-023-01647-6","volume":"8","author":"Z-Q Wang","year":"2023","unstructured":"Wang Z-Q, Zhang Z-C, Wu Y-Y, Pi Y-N, Lou S-H, Liu T-B, et al. Bromodomain and extraterminal (BET) proteins: biological functions, diseases and targeted therapy. Signal Transduct Target Therapy. 2023;8(1):420.","journal-title":"Signal Transduct Target Therapy"},{"key":"4578_CR20","doi-asserted-by":"crossref","unstructured":"Verma N, Vinik Y, Saroha A, Nair NU, Ruppin E, Mills G et al. Synthetic lethal combination targeting BET uncovered intrinsic susceptibility of TNBC to ferroptosis. Sci Adv. 2020;6(34):eaba8968.","DOI":"10.1126\/sciadv.aba8968"},{"issue":"12","key":"4578_CR21","doi-asserted-by":"publisher","DOI":"10.1038\/s41419-022-05505-1","volume":"13","author":"J Hu","year":"2022","unstructured":"Hu J, Pan D, Li G, Chen K, Hu X. Regulation of programmed cell death by Brd4. Cell Death Dis. 2022;13(12):1059.","journal-title":"Cell Death Dis"},{"issue":"5","key":"4578_CR22","doi-asserted-by":"publisher","first-page":"331","DOI":"10.1038\/s41419-019-1564-7","volume":"10","author":"S Sui","year":"2019","unstructured":"Sui S, Zhang J, Xu S, Wang Q, Wang P, Pang D. Ferritinophagy is required for the induction of ferroptosis by the bromodomain protein BRD4 inhibitor (+)-JQ1 in cancer cells. Cell Death Dis. 2019;10(5):331.","journal-title":"Cell Death Dis"},{"key":"4578_CR23","doi-asserted-by":"publisher","first-page":"207","DOI":"10.1016\/j.jare.2023.11.006","volume":"63","author":"J Sun","year":"2024","unstructured":"Sun J, Gui Y, Zhou S, Zheng XL. Unlocking the secrets of aging: epigenetic reader BRD4 as the target to combatting aging-related diseases. J Adv Res. 2024;63:207\u201318.","journal-title":"J Adv Res"},{"issue":"10","key":"4578_CR24","doi-asserted-by":"publisher","first-page":"1234","DOI":"10.1158\/2326-6066.CIR-18-0077","volume":"6","author":"DO Adeegbe","year":"2018","unstructured":"Adeegbe DO, Liu S, Hattersley MM, Bowden M, Zhou CW, Li S, et al. BET bromodomain inhibition cooperates with PD-1 blockade to facilitate antitumor response in Kras-mutant non-small cell lung cancer. Cancer Immunol Res. 2018;6(10):1234\u201345.","journal-title":"Cancer Immunol Res"},{"key":"4578_CR25","doi-asserted-by":"publisher","first-page":"116","DOI":"10.1016\/j.jconrel.2024.11.076","volume":"378","author":"Y Li","year":"2025","unstructured":"Li Y, Wu Y, Gao S, Sun T, Jiang C. PROTAC delivery in tumor immunotherapy: where are we and where are we going? J Control Release. 2025;378:116\u201344.","journal-title":"J Control Release"},{"issue":"1","key":"4578_CR26","doi-asserted-by":"publisher","first-page":"10382","DOI":"10.1038\/s41467-024-54854-2","volume":"15","author":"F Tong","year":"2024","unstructured":"Tong F, Wang Y, Xu Y, Zhou Y, He S, Du Y, et al. MMP-2-triggered, mitochondria-targeted PROTAC-PDT therapy of breast cancer and brain metastases inhibition. Nat Commun. 2024;15(1):10382.","journal-title":"Nat Commun"},{"issue":"1","key":"4578_CR27","doi-asserted-by":"publisher","DOI":"10.1186\/s12943-024-02024-9","volume":"23","author":"C Wang","year":"2024","unstructured":"Wang C, Zhang Y, Chen W, Wu Y, Xing D. New-generation advanced PROTACs as potential therapeutic agents in cancer therapy. Mol Cancer. 2024;23(1):110.","journal-title":"Mol Cancer"},{"key":"4578_CR28","doi-asserted-by":"publisher","DOI":"10.1002\/ange.202503958","author":"AG Baker","year":"2025","unstructured":"Baker AG, Ho APT, Itzhaki LS, Fruk L. Nanoparticle-mediated targeted protein degradation: an emerging therapeutics technology. Angew Chem. 2025. https:\/\/doi.org\/10.1002\/ange.202503958.","journal-title":"Angew Chem"},{"issue":"2","key":"4578_CR29","doi-asserted-by":"publisher","first-page":"e2204365","DOI":"10.1002\/advs.202204365","volume":"10","author":"Y Yang","year":"2023","unstructured":"Yang Y, Huang J, Liu M, Qiu Y, Chen Q, Zhao T, et al. Emerging Sonodynamic Therapy-Based Nanomedicines for Cancer Immunotherapy. Adv Sci (Weinh). 2023;10(2):e2204365.","journal-title":"Adv Sci (Weinh)"},{"issue":"1","key":"4578_CR30","doi-asserted-by":"publisher","DOI":"10.1186\/s12951-025-03311-3","volume":"23","author":"J Yu","year":"2025","unstructured":"Yu J, Hu JR, Tian Y, Lei YM, Hu HM, Lei BS, et al. Nanosensitizer-assisted sonodynamic therapy for breast cancer. J Nanobiotechnology. 2025;23(1):281.","journal-title":"J Nanobiotechnology"},{"issue":"11","key":"4578_CR31","doi-asserted-by":"publisher","first-page":"1688","DOI":"10.1038\/s41565-025-01990-5","volume":"20","author":"MP Purohit","year":"2025","unstructured":"Purohit MP, Yu BJ, Roy KS, Xiang Y, Ewbank SN, Azadian MM, et al. Acoustically activatable liposomes as a translational nanotechnology for site-targeted drug delivery and noninvasive neuromodulation. Nat Nanotechnol. 2025;20(11):1688\u201399.","journal-title":"Nat Nanotechnol"},{"key":"4578_CR32","doi-asserted-by":"publisher","DOI":"10.1016\/j.redox.2024.103228","volume":"74","author":"M Robert","year":"2024","unstructured":"Robert M, Kennedy BK, Crasta KC. Therapy-induced senescence through the redox lens. Redox Biol. 2024;74:103228.","journal-title":"Redox Biol"},{"issue":"17","key":"4578_CR33","doi-asserted-by":"publisher","first-page":"2420600","DOI":"10.1002\/adfm.202420600","volume":"35","author":"R Zhao","year":"2025","unstructured":"Zhao R, Feng L, Zhu Y, Yu C, Zyuzin MV, Gai S, et al. A Precision Mo4VC4-Based Nanomedicine for Effective Cancer Elimination by Harnessing Senescence Induction and Immunogenic Response. Adv Funct Mater. 2025;35(17):2420600.","journal-title":"Adv Funct Mater"},{"issue":"44","key":"4578_CR34","doi-asserted-by":"publisher","DOI":"10.1002\/smll.202402669","volume":"20","author":"F Yang","year":"2024","unstructured":"Yang F, Lv J, Ma W, Yang Y, Hu X, Yang Z. Engineering sonosensitizer-derived nanotheranostics for augmented sonodynamic therapy. Small (Weinheim an der Bergstrasse, Germany). 2024;20(44):e2402669.","journal-title":"Small (Weinheim an der Bergstrasse, Germany)"},{"key":"4578_CR35","doi-asserted-by":"crossref","unstructured":"Gong B, Zhang Q, Chen J, Qu Y, Luo X, Wang W, et al. Recent advances in Glutathione depletion-enhanced porphyrin-based nMOFs for photodynamic therapy. Pharmaceutics. 2025;17(2):244.","DOI":"10.3390\/pharmaceutics17020244"},{"issue":"1","key":"4578_CR36","doi-asserted-by":"publisher","first-page":"885","DOI":"10.1021\/acsnano.4c12304","volume":"19","author":"Y Yang","year":"2025","unstructured":"Yang Y, Wang N, Wang Z, Yan F, Shi Z, Feng S. Glutathione-responsive metal\u2013organic-framework-derived MnxOy\/(A\/R)TiO2 nanoparticles for enhanced synergistic sonodynamic\/chemodynamic\/immunotherapy. ACS Nano. 2025;19(1):885\u201399.","journal-title":"ACS Nano"},{"issue":"4","key":"4578_CR37","doi-asserted-by":"publisher","first-page":"1937","DOI":"10.7150\/thno.45511","volume":"11","author":"Q Xu","year":"2021","unstructured":"Xu Q, Zhan G, Zhang Z, Yong T, Yang X, Gan L. Manganese porphyrin-based metal-organic framework for synergistic sonodynamic therapy and ferroptosis in hypoxic tumors. Theranostics. 2021;11(4):1937\u201352.","journal-title":"Theranostics"},{"key":"4578_CR38","doi-asserted-by":"publisher","first-page":"4725","DOI":"10.2147\/IJN.S381170","volume":"17","author":"S Chen","year":"2022","unstructured":"Chen S, Wang J, Liao H, Tang K, Xu Y, Wang L, et al. M1 Macrophage-Derived Sonoresponsive Nanoparticles for Sonodynamic Anticancer Therapy. Int J Nanomed. 2022;17:4725\u201341.","journal-title":"Int J Nanomed"},{"key":"4578_CR39","doi-asserted-by":"publisher","first-page":"122456","DOI":"10.1016\/j.biomaterials.2023.122456","volume":"305","author":"S Chen","year":"2024","unstructured":"Chen S, Ma T, Wang J, Liang S, Liao H, Tan W, et al. Macrophage-derived biomimetic nanoparticles enhanced SDT combined with immunotherapy inhibited tumor growth and metastasis. Biomaterials. 2024;305:122456.","journal-title":"Biomaterials"},{"issue":"29","key":"4578_CR40","doi-asserted-by":"publisher","first-page":"41680","DOI":"10.1021\/acsami.5c07008","volume":"17","author":"Z Liao","year":"2025","unstructured":"Liao Z, Liao H, Luo Y, Chen S, Chen M, He J, et al. Red Blood Cell Membrane-Camouflaged Nanoparticles for Synergistic Sonodynamic Therapy and TGF-\u03b2 Inhibition to Reprogram Immunosuppressive Tumor Microenvironment. ACS Appl Mater Interfaces. 2025;17(29):41680\u201395.","journal-title":"ACS Appl Mater Interfaces"},{"issue":"1","key":"4578_CR41","doi-asserted-by":"publisher","first-page":"432","DOI":"10.1186\/s12951-025-03485-w","volume":"23","author":"H Liao","year":"2025","unstructured":"Liao H, Chen M, Liao Z, Luo Y, Chen S, Tan W, et al. Sonodynamic therapy-boosted biomimetic nanoplatform targets ferroptosis and CD47 as vulnerabilities for cancer immunotherapy. J Nanobiotechnol. 2025;23(1):432.","journal-title":"J Nanobiotechnol"},{"issue":"1","key":"4578_CR42","doi-asserted-by":"publisher","first-page":"4267","DOI":"10.1038\/s41467-024-46533-z","volume":"15","author":"H Kong","year":"2024","unstructured":"Kong H, Zheng C, Yi K, Mintz RL, Lao Y-H, Tao Y, et al. An antifouling membrane-fusogenic liposome for effective intracellular delivery in vivo. Nat Commun. 2024;15(1):4267.","journal-title":"Nat Commun"},{"issue":"25","key":"4578_CR43","doi-asserted-by":"publisher","first-page":"23276","DOI":"10.1021\/acsnano.5c06202","volume":"19","author":"Y Zhao","year":"2025","unstructured":"Zhao Y, Liu T, Wang Y, Li L, Lin X, Wang W, et al. Cancer Cell Membrane-Coated Homodimer Prodrug Nanoassemblies to Simultaneously Deliver Prodrugs and Immune Adjuvants for Combined Chemo-Immunotherapy. ACS Nano. 2025;19(25):23276\u201393.","journal-title":"ACS Nano"},{"issue":"6","key":"4578_CR44","first-page":"2407245","volume":"21","author":"S Chen","year":"2025","unstructured":"Chen S, Lan H, Liu M, He C, Li Q, Zheng S, et al. Less is More: Biomimetic Hybrid Membrane Nanocarriers for Highly Efficient Tumor. Target Drug Delivery. 2025;21(6):2407245.","journal-title":"Target Drug Delivery"},{"issue":"13","key":"4578_CR45","doi-asserted-by":"publisher","first-page":"6193","DOI":"10.1021\/acs.nanolett.3c01812","volume":"23","author":"LP Zhao","year":"2023","unstructured":"Zhao LP, Rao XN, Zheng RR, Huang CY, Kong RJ, Cheng H, et al. Carrier-free Nano-PROTACs to amplify photodynamic therapy induced DNA damage through BRD4 degradation. Nano Lett. 2023;23(13):6193\u2013201.","journal-title":"Nano Lett"},{"issue":"Pt 1","key":"4578_CR46","doi-asserted-by":"publisher","DOI":"10.1016\/j.jconrel.2025.114290","volume":"388","author":"H Zhou","year":"2025","unstructured":"Zhou H, Luo X, Huang C, Liu Y, Li Q, Chen G, et al. A dual PROTAC nanocarrier amplifies DNA damage and STING activation for cancer immunotherapy. J Control Release. 2025;388(Pt 1):114290.","journal-title":"J Control Release"},{"issue":"15","key":"4578_CR47","volume":"11","author":"LP Zhao","year":"2024","unstructured":"Zhao LP, Zheng RR, Rao XN, Huang CY, Zhou HY, Yu XY, et al. Chemotherapy-enabled colorectal cancer immunotherapy of self-delivery nano-PROTACs by inhibiting tumor glycolysis and avoiding adaptive immune resistance. Advanced science (Weinheim, Baden-Wurttemberg, Germany). 2024;11(15):e2309204.","journal-title":"Advanced science (Weinheim, Baden-Wurttemberg, Germany)"}],"container-title":["Journal of Nanobiotechnology"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/link.springer.com\/article\/10.1186\/s12951-026-04578-w","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1186\/s12951-026-04578-w.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1186\/s12951-026-04578-w.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2026,7,20]],"date-time":"2026-07-20T12:02:58Z","timestamp":1784548978000},"score":1,"resource":{"primary":{"URL":"https:\/\/link.springer.com\/10.1186\/s12951-026-04578-w"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2026,5,23]]},"references-count":47,"journal-issue":{"issue":"1","published-online":{"date-parts":[[2026,12]]}},"alternative-id":["4578"],"URL":"https:\/\/doi.org\/10.1186\/s12951-026-04578-w","relation":{},"ISSN":["1477-3155"],"issn-type":[{"value":"1477-3155","type":"electronic"}],"subject":[],"published":{"date-parts":[[2026,5,23]]},"assertion":[{"value":"25 February 2026","order":1,"name":"received","label":"Received","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"13 May 2026","order":2,"name":"accepted","label":"Accepted","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"23 May 2026","order":3,"name":"first_online","label":"First Online","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"All animal experiments were conducted in strict accordance with ARRIVE guidelines and approved by the Ethics Committee of the Second Xiangya Hospital, Central South University (20250090).","order":1,"name":"Ethics","label":"Ethics approval and consent to participate","group":{"name":"EthicsHeading","label":"Declarations"}},{"value":"All authors have approved the manuscript and agree for the submission.","order":2,"name":"Ethics","label":"Consent for publication","group":{"name":"EthicsHeading","label":"Declarations"}},{"value":"The authors declare no competing interests.","order":3,"name":"Ethics","label":"Competing interests","group":{"name":"EthicsHeading","label":"Declarations"}}],"article-number":"678"}}